Imexpharm Corporation reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported revenue was VND 466,920.37 million compared to VND 417,849.65 million a year ago. Net income was VND 69,704.86 million compared to VND 55,789.57 million a year ago. Basic earnings per share from continuing operations was VND 889 compared to VND 711 a year ago.
For the nine months, revenue was VND 1,385,883.73 million compared to VND 1,086,546.4 million a year ago. Net income was VND 227,206.58 million compared to VND 155,002.99 million a year ago. Basic earnings per share from continuing operations was VND 2,759.0476 compared to VND 1,881.9048 a year ago.